Invests in categories: AdTechBioTechDevelopmentHealthcareHealthTechManagementMedTechProductServiceTechnology
Créée en 2001, ANDERA PARTNERS, est une référence de l’investissement non coté en France et à l’international. Elle gère près de 2,5 milliards d’euros autour des sciences de la vie (Andera Life Sciences), du capital développement et de la transmission (Andera MidCap et Andera Expansion), de la dette mezzanine sponsorless (Andera Acto) et de la transition énergétique (Andera Infra).
News
231
Portfolio
302
Persons
153
Mentions
107
Location: France, Ile-de-France
Employees: 51-200
Investment Stage: Series A; Series B; Series C; Series D; Series E
Portfolio 302
Show more
Persons 153
| Date | First Name | Last Name | Title | Location | |||
| - | Livia | Haag | Senior Man... | - | - | - | |
| - | Laurent | Fichter | Partner an... | linkedin.c... | - | l*******r@... | - |
| - | Jean-Bapti... | Bessières | Partner an... | linkedin.c... | - | j*********... | - |
| - | Anne-Laure | Delavergne | Middle Off... | - | a*********... | - | |
| - | Etienne | Rossignol | Investment... | linkedin.c... | - | e*********... | - |
| - | Sofia | Ioannidou | Partner an... | linkedin.c... | - | s*********... | - |
| - | Camille | Coll | Investment... | linkedin.c... | - | - | - |
| - | Pierre | Flin | Investment... | linkedin.c... | - | p****n@and... | - |
| - | Vincent | Bazzocchi | Director a... | linkedin.c... | - | v*********... | - |
| - | Armelle | Okoye | Middle Off... | - | - | - | |
| - | Vanessa | Favier-Kla... | Chief Oper... | linkedin.c... | - | v*********... | - |
| - | Marie | Coquille | Senior Inv... | linkedin.c... | - | m********e... | - |
| - | Jeanne | Chabenat | Analyst an... | linkedin.c... | - | - | - |
| - | Noëlla | De Berming... | Chief Sust... | linkedin.c... | - | n*********... | - |
| - | Simon | Balagué | Chief Comp... | linkedin.c... | - | s*******e@... | - |
| - | Nicolas | Debonneuil | Investment... | linkedin.c... | - | n*********... | - |
| - | Erwan | Prigent | Commercial... | linkedin.c... | - | e*******t@... | - |
| - | Albane | Richard | Investment... | linkedin.c... | - | a*******d@... | - |
| - | Mathieu | Piéronne | Director a... | linkedin.c... | - | m********e... | - |
| - | Louis | Vazeux | Analyst an... | - | - | - | |
| - | Antoine | Guérillon | Senior Inv... | linkedin.c... | - | a*********... | - |
| - | Mathis | Merlot | Investment... | linkedin.c... | - | m******t@a... | - |
| - | Yuexin | Yu | Director a... | linkedin.c... | - | - | - |
| - | Eloïse | Arriberoug... | Communicat... | - | - | - | |
| - | Aurélie | Owona (Den... | Director a... | linkedin.c... | - | a********l... | - |
| - | Florian | Gerard-Mer... | Investment... | linkedin.c... | - | f*********... | - |
| - | Alexander | Cuniasse | Partner | linkedin.c... | - | - | - |
| - | Héloïse | Klitting | Sustainabi... | linkedin.c... | - | h********g... | - |
| - | Theresa | Dias Marqu... | Team Assis... | linkedin.c... | - | t*********... | - |
| - | Thibault | Menel | Investment... | linkedin.c... | - | t*****l@an... | - |
| - | Nicolas | Delsert | Chief Comm... | linkedin.c... | - | n*******t@... | - |
| - | Julien | Huau | Sustainabi... | - | - | - | |
| - | Bruno | Bonnin | Partner | linkedin.c... | - | - | - |
| - | Mickael | Clavier | Chief Digi... | - | - | - | |
| - | Anissa | Peer | Analyst | linkedin.c... | - | a****r@and... | - |
| - | Coralie | Dabiens | Sustainabi... | - | - | - | |
| - | Vincent | Croci | Senior Inv... | linkedin.c... | - | v*****i@an... | - |
| - | Filippo | Alberti | Senior Man... | - | - | - | |
| - | Flavien | Laboudigue | Senior Fin... | linkedin.c... | - | f*********... | - |
| - | Francesco | Gonzaga | Partner an... | linkedin.c... | - | f*******a@... | - |
| - | Pierre | Barruet | Director o... | linkedin.c... | - | p*******t@... | - |
| - | Maurizio | Bottinelli | Senior Adv... | linkedin.c... | - | - | - |
| - | Alvaro | Canosa | Investment... | linkedin.c... | - | - | - |
| - | Amira | Mehlal | Middle Off... | linkedin.c... | - | - | - |
| - | Thierry | Hercend | Venture Pa... | - | t*******d@... | - | |
| - | Elyes | Chouaieb | Investment... | linkedin.c... | - | e********b... | - |
| - | Jérémy | Afriat | Investment... | linkedin.c... | - | j******t@a... | - |
| - | Maria | Arce Avila | General Se... | linkedin.c... | - | m*********... | - |
| - | Elisabeth | Mazières | Accountant... | - | e********s... | - | |
| - | Lounès | Moumou | Analyst an... | linkedin.c... | - | - | - |
| - | Laetitia | Guetta | Head of HR | linkedin.c... | - | l******a@a... | - |
| - | Anne-Clair... | Picchiotti... | Investment... | linkedin.c... | - | a*********... | - |
| - | Sophie | Debert-Pér... | Investor R... | linkedin.c... | - | s*********... | - |
| - | Gregory | Mengus | Assistant ... | linkedin.c... | - | - | - |
| - | Wesley | Peang | Financial ... | - | w*****g@an... | - | |
| - | Katia | von Borows... | Investment... | linkedin.c... | - | - | - |
| - | Clément | Legendre | Analyst an... | linkedin.c... | - | - | - |
| - | Charles | Guion de M... | Investment... | linkedin.c... | - | c*********... | - |
| - | Pierre | Millot | Director a... | linkedin.c... | - | p******t@a... | - |
| - | Kadiatou | Baldé | IT Project... | - | - | - | |
| - | Ines | Da Silva | HR Officer | linkedin.c... | - | - | - |
| - | Louis | Hamon | Partner | linkedin.c... | - | - | - |
| - | Marlène | Stablo | IT and Gen... | linkedin.c... | - | m******o@a... | - |
| - | Julia | Joannot | Senior Inv... | linkedin.c... | - | j*******t@... | - |
| - | Emmanuelle | Payet | Middle Off... | linkedin.c... | - | e*****t@an... | - |
| - | Loan | Hoang-Saya... | Venture Pa... | linkedin.c... | - | l*********... | - |
| - | Maxime | Sabourin | Senior Man... | linkedin.c... | - | - | - |
| - | Solenn | Riffaud | Accounting... | linkedin.c... | - | s*******d@... | - |
| - | Ana | Flavia Gui... | Investor R... | linkedin.c... | - | a********i... | - |
| - | Vanessa | Bonvalot | Executive ... | linkedin.c... | - | v********t... | - |
| - | Laurent | Tourtois | Partner an... | linkedin.c... | - | l********s... | - |
| - | Gonzalo | Boada | Director a... | linkedin.c... | - | - | - |
| - | Carlo | Cartapani | Investment... | linkedin.c... | - | c*********... | - |
| - | Souhaila | Tnifoui | Financial ... | - | - | - | |
| - | Pierre-Luc | Wilain de ... | Investment... | linkedin.c... | - | p*********... | - |
| - | Guillaume | Thomas | Director a... | linkedin.c... | - | g******s@a... | - |
| - | Emma | Morvan | HR Assista... | linkedin.c... | - | e******n@a... | - |
| - | Gilles | Nobécourt | Partner an... | linkedin.c... | - | g*********... | - |
| - | Jan | Van den Bo... | Partner an... | linkedin.c... | - | j*********... | - |
| - | Mayeul | Caron | Partner An... | linkedin.c... | - | m*****n@an... | - |
| - | Nicolas | Boby | Analyst an... | linkedin.c... | - | n****y@and... | - |
| - | Augustin | Bayvet | Senior Inv... | linkedin.c... | - | a******t@a... | - |
| - | Arthur | Milliard | Director a... | linkedin.c... | - | a********d... | - |
| - | Prune | Des Roches | Partner an... | - | - | - | |
| - | Gladys | Grolier | Legal Advi... | linkedin.c... | - | g*******r@... | - |
| - | Thomas | Guyenot | Investment... | linkedin.c... | - | t*******t@... | - |
| - | Quentin | Tarasconi | Investment... | linkedin.c... | - | q*********... | - |
| - | Loïc | Guyomard | Financial ... | linkedin.c... | - | - | - |
| - | Valentin | Proux | IT Project... | - | - | - | |
| - | Clarisse | Bayol | Senior Com... | linkedin.c... | - | c*****l@an... | - |
| - | Antoine | Le Bourgeo... | Partner an... | linkedin.c... | - | a*********... | - |
| - | Serge | Prosman | Senior Adv... | linkedin.c... | - | - | - |
| - | Cécile-Lau... | Fansi | Middle Off... | linkedin.c... | - | c******i@a... | - |
| - | Sylvain | Charignon | Partner an... | linkedin.c... | - | s*********... | - |
| - | Delphine | Cordier | Accountant... | - | d*******r@... | - | |
| - | Andrei | Buzdugan | CFO and re... | linkedin.c... | - | a********n... | - |
| - | Aneta | Sottil | Partner an... | linkedin.c... | - | a******l@a... | - |
| - | Christine | Martinovic | Director a... | linkedin.c... | - | c*********... | - |
| - | Achille | Robert | Manager an... | linkedin.c... | - | a******t@a... | - |
| - | Vanessa | Valluet | Team Assis... | linkedin.c... | - | v*******t@... | - |
| - | Marianne | Harlé | Partner An... | linkedin.c... | - | m*****e@an... | - |
Show more
News 231
| Date | Title | Description |
| 15.07.2026 | 2025 Sustainability Report | At Andera Partners, we have long believed that our role extends beyond capital deployment. As long-term partners to European SMEs and mid-caps, we support companies in building the foundations that create resilience over time, often startin... |
| 08.07.2026 | Andera Partners announces a record €430M fundraise for Andera Expansion. | A CLEAR AND PROVEN INVESTMENT STRATEGY The new AE IV fundraise is underpinned by particularly solid fundamentals, starting with a top quartile track record. The Expansion team has completed 32 exits with an average multiple of 3.6x, enablin... |
| 29.06.2026 | Andera Partners joins the European Life Sciences Coalition (ELSC) with the aim to support the mobilization of capital for life sciences innovation in Europe. | Andera Partners joins the European Life Sciences Coalition (ELSC), alongside Forbion, HealthCap, Novo Holdings, Omega Funds, Sofinnova Partners, Van Lanschot Kempen, VIB, BioInnovation Institute, 4BIO Capital, Cooley and Covington. Launched... |
| 29.06.2026 | “Health is Wealth”: Why Europe must act now to strengthen its Life Sciences industry. | Dear Presidents, Heads of State and Government, Europe must preserve and strengthen its leadership in Life Sciences at a time when health, economic security, and technological sovereignty are becoming increasingly important. On 12 February,... |
| 13.05.2026 | Andera Partners Leads $20 Million Series D Financing in Rivermark Medical. | Andera Partners, a leading European venture capital and private equity firm, today announced it led a $20 million Series D financing in Rivermark Medical, Inc., a urology-focused medical device company committed to redefining benign prostat... |
| 11.05.2026 | Andera Infra sells its stake in Nostrum Group to IREN, listed on the NASDAQ. | Based in Spain and founded in 2009 as an engineering company operating in the renewable energy sector where it built a strong track record, Ingenostrum, S.L. is a next-generation data center developer. A key milestone in its evolution was t... |
| 20.04.2026 | Real Deals – Best Multi-Strategy House of the Year | We are honoured to have been named Best Multi-Strategy House of the Year at the Real Deals Private Equity Awards 2026, our first international recognition of this kind. This award reflects the vision we have been building for years: a cons... |
| 09.04.2026 | Tecnikabel acquires EIS Wire & Cable, expanding its presence in the USA within the industrial automation and defence sectors. | Tecnikabel, an international leader in the design and manufacture of specialty cables, connection systems and cable assemblies, announces the acquisition of South Hadley, Massachusetts-based (U.S.) EIS Wire & Cable (“EIS”), a company sp... |
| 07.04.2026 | Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline. | Andera Partners today announced that Gilead Sciences, Inc. (Nasdaq: GILD) has entered into a definitive agreement to acquire Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company developing next-generation antibody-dru... |
| 05.03.2026 | Andera Partners accelerates its development in Spain and appoints Joaquín Gonzalo for its sponsorless mezzanine strategy. | This development comes at a time when Andera Acto recently announced the successful closing of its latest fund Acto V at €1.1 billion and has strong ambitions in terms of internationalization of dealmaking. Over the last months, the team al... |
| 26.02.2026 | S4BT acquires HotelHub to become the ultimate powerhouse in global business travel. | The transaction marks a new phase of scale and ambition for the Group, expanding its geographical reach, deepening engagement across major travel markets, and enhancing its technological capacity. Both S4BT and TCT’s Management were already... |
| 19.02.2026 | Andera Acto invests in the Austrian company exceet Card Group | Andera Partners announced its management-sponsored mezzanine investment in the exceet Card Group, based in Kematen in Tyrol (Austria). This is already the ninth transaction for Acto V. This financing enables the company’s founders to increa... |
| 18.02.2026 | Bruno Angles becomes Strategic Advisor to Andera Partners | Andera Partners continues its transformation and structural scale-up and confirms its position as one of the leading GPs in the European private equity market. This momentum has been underpinned in recent months by a number of major milesto... |
| 17.02.2026 | Andera Partners strengthens its position among the leading players in private equity | Against an economic and financial backdrop marked in 2025 by a global slowdown and a sharp downturn in the private equity market – fund investments were down by more than 20% in France – Andera Partners is continuing to implement its strate... |
| 09.02.2026 | Agomab, portfolio company of Andera Partners, completes successful Nasdaq listing with $200 million IPO | Andera Partners announced today that Agomab, one of its portfolio companies, has completed a $200 million initial public offering on the NASDAQ stock market. The Company is trading under the ticker AGMB and it made its public market debut o... |
| 04.02.2026 | Andera Partners announces the final closing of Acto V at 1.1 billion euros, exceeding its hard cap. | PAN-EUROPEAN ACCELERATION: A FUND ALREADY IN ACTION This closing comes at a time when Andera Acto is stepping up its pan-European deployment. In 2025, the team set up a network of Senior Advisors in Belgium, Germany, and Italy, soon to be j... |
| 03.02.2026 | Venture Capital Fellowship – Andera Life Sciences | The Andera Life Sciences team is looking for an intern for a period of 6 months, starting this spring. Responsibilities: Required: The internship will take place at our Paris office (physical presence required). We encourage applications fr... |
| 26.01.2026 | The Europeanisation of Private Equity: Transcending Borders to Build an Integrated Platform. | This white paper explores the Europeanization of private equity through 3 parts: organizational models, operational and sector-specific challenges, and the realities of major European markets. The objective: to provide concrete insights int... |
| 20.01.2026 | Andera Partners’ Portfolio Company Exciva Secures €51 Million Series B to Advance Clinical Program for Alzheimer’s-Related Agitation. | Andera Partners, a leading European private equity player, today announced that it participated in the €51 million ($59 million) Series B financing round of its portfolio company Exciva GmbH, a biopharmaceutical company developing novel the... |
| 08.01.2026 | Andera Partners co-leads $160 Million Series A round for Alveus to Advance Next-Generation Therapies for Obesity and Metabolic Diseases | Andera Partners, a leading European private equity player, today announced that it is co-leading a $159.8 million Series A round of Alveus Therapeutics, a clinical-stage biotechnology company developing next-generation therapies for obesity... |
| 07.01.2026 | Andera Partners Leads $67 Million Series A Financing in Spiro Medical to Develop a Neuromodulation System for Asthma. | The financing included a syndicate of venture investors led by Andera Partners (Paris), Omega Funds (Geneva) and Sherpa Healthcare Partners (Cayman Islands) and joined by HSG (Hong Kong), Supernova Invest (Paris), Northern Light Venture Cap... |
| 03.12.2025 | Andera Partners supports the creation of a global champion in Test & Quality Engineering through the combination of Spherea and Averna | Under the terms of the agreement, Andera Partners will become the majority shareholder of the newly combined Group, marking a major milestone in both companies’ shared ambition to become the largest independent and global player in Test &am... |
| 07.11.2025 | Andera Partners’ portfolio company Evommune successfully lists on New York Stock Exchange with a $150 million IPO | Andera Partners today announced that it participated in the $150 million IPO on NYSE of its portfolio company Evommune, demonstrating Andera’s continued support of the company’s value creation through clinical development and pipeline expan... |
| 23.10.2025 | Andera Partners invests in Adler Ortho, leading player in premium orthopedic implants and bioresorbable products | Andera Partners, one of Europe’s leading private capital firms with headquarters in Paris and almost €5.0 billion in assets under management, has completed its investment in Adler Ortho, an internationally renowned player active in the desi... |
| 22.10.2025 | Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline | Ipsen (Euronext: IPN; ADR: IPSEY) and ImCheck Therapeutics today announced they have entered into a definitive share purchase agreement in which Ipsen will acquire all issued and outstanding shares of ImCheck Therapeutics, a private French ... |
| 16.10.2025 | Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund | Andera Partners, a leading European private equity player, today announced that it has co-led the Series A financing round of Adcytherix, a biopharmaceutical company developing novel and proprietary antibody drug conjugates (ADC). The trans... |
| 15.10.2025 | Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline | Andera Partners, a leading European private equity player, today announced that it participated in the €308 million (USD 361 million) Series C financing of its portfolio company Tubulis, underscoring Andera’s continued support of the compan... |
| 23.07.2025 | Andera Partners Strengthens Its Presence In Spain With The Appointment Of Ignacio Moreno Martínez As Senior Advisor. | Ignacio Moreno, currently Non-Executive Chairman of Metrovacesa and a board member of Telefónica Brazil and GAM among others, brings extensive experience in the private equity sector. He has served as CEO of two of Spain’s leading private e... |
| 01.07.2025 | 2024 Sustainability Report | We are pleased to present our latest Sustainability Report, highlighting the progress achieved by Andera Partners and its portfolio companies over the past year: Climate – advancing decarbonizationOur climate strategy, aligned with the Scie... |
| 16.06.2025 | New White Paper: Managing Water Risks & Building Resilient Portfolios. | Water scarcity, pollution, and climate disruption are reshaping investment strategies. With 32% of our portfolio exposed to water quality risks and 26% to quantity risks, integrating water into our Sustainability Strategy is no longer optio... |
| 12.06.2025 | Andera Acto increases international development and announces two strategic appointments | Sébastien Neiss, Senior Advisor Germany Sébastien is responsible for establishing sponsorless financing activities on the German market for Andera Acto. With three years in finance, 16 years in M&A on the Germany-France axis and seven y... |
| 22.05.2025 | Andera Partners announces the signing of an exclusive agreement with Ardian to acquire a majority stake in MasterGrid alongside the Management team | Headquartered in Grenoble and historically a business unit of Siemens, MasterGrid was carved out by Siemens to Andera Partners in 2019. Since then, the Group, which was focused on the manufacturing and maintenance of Merlin Gerin installed ... |
| 24.04.2025 | Andera Partners strengthens its presence in Belgium and announces the recruitment of a Senior Advisor for its sponsorless mezzanine strategy | Boasting over 25 years’ experience in M&A at Deloitte, including 5 years in London, Serge Prosman has acquired solid expertise in sourcing and completing mid-market transactions in a wide range of sectors. He was a Partner for 17 years ... |
| 07.03.2025 | Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering. | BofA Securities, Goldman Sachs & Co. LLC and Piper Sandler acted as lead bookrunners for the offering. Wells Fargo Securities and Stifel acted as bookrunners and Wolfe | Nomura Alliance acted as co-manager for the offering. A registrati... |
| 03.03.2025 | Boston Scientific announces agreement to acquire SoniVie Ltd. | Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS™ Intravascular Ultrasound System. An investig... |
| 20.02.2025 | EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development | EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful closing of a €27 million Series B financing round co-led by Andera Partners an... |
| 11.02.2025 | With 2024 marked by AUM growth and dynamic liquidity, Andera Partners pursues its development in 2025 by relying on its new partner Candriam | Andera Partners, a leading player in private equity, had a particularly active year in 2024 with €683 million deployed (+10% as compared with 2023), €436 million in disposal proceeds and €650 million raised. Through its six investment teams... |
| 03.02.2025 | Andera Partners invests together with founder and historical shareholders of CDS Group | Established in 2001, CDS offers a complete digital platform enabling its clients (large companies and travel agencies dedicated to companies) to manage the entire business hotel reservation chain and to generate savings on direct and indire... |
| 20.01.2025 | Ayming joins forces with Andera Partners to accelerate its development alongside the management team. | Ayming, a global leader in performance consulting, specializing in innovation financing in France and internationally, as well as HR management in France, announces the entry of Andera Partners as a majority shareholder through its Andera M... |
| 14.01.2025 | Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology | Bioptimus, the pioneering AI foundation model company,announced today that it has reached a significant funding milestone of $76 million. This total includes a $41 million cash injection, led by Cathay Innovation with participation from pro... |
| 12.12.2024 | New York Life Investments and its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners | New York Life Investments, Candriam and Andera Partners (Andera) announced today plans to enter into a strategic partnership whereby New York Life Investments, a diversified, global asset management firm with $750 billion in assets under ma... |
| 14.11.2024 | Horus Finance joins forces with Andera Partners to accelerate the development of its fine arts logistics division (“Fine Arts division”) | A legacy player with unmatched expertise Established in 1760 as the French royal family’s exclusive layetier under the name André Chenue, Horus Finance’s Fine Arts division stems from a rich legacy of prestigious brands such as Natural Le C... |
| 13.11.2024 | Andera Partners continues its international expansion and announces the opening of a Madrid office | Gonzalo Boada joins Andera Partners as a Director within the Andera MidCap team, which invests in medium-sized companies (with revenue between €50 and €500 million) to accelerate their change of scale and their internationalization. The mai... |
| 05.11.2024 | PM Studio has conclude a deal with Andera Partners to begin a new development phase and become a key player in its market consolidation | Andera Partners, a leading player in private equity – especially in the small and mid market through its Andera Expansion team – has become a key shareholder in PM Studio, a leading company from the design to the manufacture of promotional ... |
| 25.10.2024 | Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-focused Pipeline | Agomab Therapeutics NV (‘Agomab’) today announced a $89 million (€82.1 million) Series D financing round, with participation from new investors Sanofi and Invus, as well as existing investors. The proceeds from the Series D will be used to ... |
| 14.10.2024 | Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study | Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohe... |
| 10.09.2024 | Skysun secures a Series A funding round to develop and manage a photovoltaic portfolio of over 300 million euros by 2030. | Skysun is an independent energy production company specializing in the development, installation, and management of solar panels for businesses (third-party investor). In 2020, the company had already secured €5 million in subordinated debt... |
| 05.09.2024 | Andera Partners welcomes Bruno Bonnin as Partner | Andera Acto, the mezzanine sponsorless investment team of Andera Partners, strengthens its ranks by welcoming its 5th partner, Bruno Bonnin. Bruno Bonnin (40 years old, Centrale Lyon; HEC) joins Andera Partners in September 2024 as a partne... |
| 26.07.2024 | Andera Partners and Equiter invest in Tecnikabel, the Italian leader in specialty cables, harnesses and connectors | Andera Partners, one of Europe’s leading private capital firms with headquarters in Paris and over €4.2 billion of asset under management, has completed its investment in a majority stake of Tecnikabel Group, the Italian leader in high valu... |
| 26.07.2024 | Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors | Kestra Medical is an American company also present in Ireland, which has developed and commercializes a medical device: a vest equipped with a portable defibrillator for patients at risk of sudden cardiac arrest. The $196 million financing ... |
| 25.07.2024 | Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones | Andera Partners, a leading European private equity player, announced today that its portfolio company TRiCares, a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, has raised $50 million (approx... |
| 25.07.2024 | Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences | Andera Partners, a leading European private equity player, announced today that its portfolio company, JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), will be acquired by Edwards Lifesciences, a ... |
| 15.07.2024 | Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca | Andera Partners, a leading European private equity player, announced today that its portfolio company Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and r... |
| 09.07.2024 | Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom | Andera Partners, a leading European private equity player, announced today that it is co-leading a € 63 million ($ 70 million) Series A financing for SciRhom, a biopharmaceutical company pioneering the development of first-in-class therapeu... |
| 02.07.2024 | 2023 Sustainability Report | Andera Partners unveils a Sustainability strategy encompassing responsible investment, climate, biodiversity, inclusion, and value-sharing. Our ambitions have significantly strengthened this year with the alignment of our climate strategy w... |
| 27.06.2024 | Spengler Group takes on a European dimension with the acquisition of German manufacturer Luxamed | A year after completing the two transformational acquisitions of Dessillons & Dutrillaux and Electro Concept Médical, Spengler Group has become a key European player in the manufacture of high added-value medical equipment with the acqu... |
| 14.03.2024 | Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca | Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced it has entered into a definitive agreement for AstraZeneca to acquire... |
| 14.03.2024 | Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline | Andera Partners’ portfolio company Tubulis today announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. The round was co-led by EQT Life Sciences and Nextech Invest Ltd, on be... |
| 28.02.2024 | Andera Partners raises a final amount of € 233 million for Andera Smart Infra 1, its first fund dedicated to renewable energy transition | The fundraising of Andera Smart Infra 1 highlights the strong interest of investors (including the European Investment Fund under InvestEU) in green infrastructure, resulting from renewable energy and ecological transition requirements. Thi... |
| 21.02.2024 | MMI Raises $110 Million in Series C Financing | The funds will support commercialization of the Symani® Surgical System in high-growth markets and continued investment in studies that generate clinical evidence and enable indication expansion. Investments will also accelerate advanced te... |
| 12.02.2024 | 2023 Report – After a record year of investments and exits, Andera Partners sets a target of 7 to 8 billion Euros in AUM by 2028 and announces its European ambitions | Andera Partners, a leading private equity investment firm, had a particularly active 2023, with €627 million deployed (+25% as compared with 2022), €790 million in sales proceeds (+53%) and €680 million in new funds raised. Through its six ... |
| 12.02.2024 | Internship Offer – Andera Life Sciences | Andera Life Sciences, part of Andera Partners, is one of the leading Life Sciences venture capital teams in Europe and manages funds investing in therapeutics and medical devices. Through its Biodiscovery 6 fund, the team currently invests ... |
| 24.01.2024 | Meogroup initiates a new development cycle with the support of Andera Partners | Since its inception by Richard Caron in 2005, Meogroup has specialised in providing operational support to its clients in their performance challenges. Based in France and present in Europe (Belgium, Italy, Spain, Switzerland, Luxembourg) a... |
| 23.01.2024 | Andera Partners welcomes Sophie ELKRIEF as Business Development Partner | Sophie ELKRIEF has worked her entire career in the financial sector. She started in investment banking (1996-2001) in London and New York (Salomon Smith Barney, JP Morgan) prior to moving to asset management firstly with Dexia Asset Managem... |
| 18.01.2024 | Mistertemp’ group announces the reorganization of its shareholding: Andera Partners succeeds Montefiore Investment | Established in 2009 and based in Paris, Mistertemp’ group provides a multichannel offer of HR services (temporary work and recruitment) in France and in Europe. The group initiated a radical change to its market based on an approach combini... |
| 21.12.2023 | Spanish energy transition developer INGENOSTRUM accelerates, with a fund raising of 25M€ from Andera Partners | The expert in renewable energy project development |
| 14.12.2023 | The Efor Group joins forces with the Nodarius Group, which includes the Altogen brand, to strengthen its position as a European leader in specialized life sciences consulting. | Driven by its dynamism and market recognition, the group aims to extend its international scope, particularly in Europe and the USA, invest in the development of its offerings and expertise, and reach 5,000 employees by 2028. Its strategy w... |
| 05.12.2023 | The Imagerie Cardinet Group strengthens its position to accelerate its entrepreneurial model | Established in 1980, Imagerie Cardinet is a medical imaging group operating in Ile-de-France. The group provides complete healthcare services, with a recognised specialty in imaging for women, couples and children. Based on its dynamic grow... |
| 30.11.2023 | mylight150 secures €100m to accelerate the expansion of its solar self-consumption & smart energy management solutions in Europe. | The leader in solar self-consumption solutions |
| 14.11.2023 | Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immunotherapy company Nouscom | Andera Partners, a leading European private equity player, today announces that it is co-leading a €67.5 million ($72 million) oversubscribed Series C financing for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf ... |
| 13.11.2023 | Andera Partners joins forces with Founders of Gosto Group in providing support in their international development on commercial furniture market | Established in 1998 in Wasquehal, the Gosto Group is a multichannel distributor of commercial, office and warehouse furniture, marketed via twelve owner websites including Gosto.com or Espace Equipement ; and directly via its physical showr... |
| 27.10.2023 | JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints | The trial met prespecified non-inferiority criteria for its primary safety endpoint and primary efficacy endpoint. Outcomes were presented by Dr. Vinod Thourani (Piedmont Heart Institute, Atlanta, GA) during the opening Late-Breaking Clinic... |
| 11.10.2023 | Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline | Agomab Therapeutics NV (‘Agomab’) today announced the closing of a $100 million (€94.9 million) Series C financing round led by Fidelity Management & Research Company, with participation from new investors EQT Life Sciences (EQT), Canaa... |
| 10.10.2023 | ELAN Languages acquires Dutch company AVB Vertalingen | ElaN Languages, which has a turnover of around €30m following the June 2023 acquisition of Lingua-World in Germany, has built up a solid reputation for the quality of its services to a highly demanding clientele, including the Belgian and G... |
| 05.10.2023 | Andera Acto supports EFOR’s ambition of becoming a global leader in its market within five years | Since its inception, EFOR has demonstrated continuous growth exceeding 20% per year in a resilient market, in full globalization and in search of trusted players to outsource strategic activities throughout the product life cycle, requiring... |
| 05.10.2023 | Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts STENOVA Phase 2a Clinical Trial | Agomab Therapeutics NV (‘Agomab’) announces that it received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for AGMB-129 for the potential treatment of Fibrostenosing Crohn’s Disease (FSCD). In addition, Agomab has ... |
| 04.10.2023 | Andera Partners completes full exit from Travelsoft Group and hands over to CAPZA | - |
| 18.09.2023 | Andera Partners increases the hard cap for Andera MidCap 5 and raises a final amount of €750 million | This fundraising success highlights the strong interest investors have in the deep and resilient European and French Lower-Mid Market, as well as in the change of scale strategy led by Andera MidCap which has already delivered solid perform... |
| 24.07.2023 | Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours | Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, today announces that it plans to augment the ongoing Phase 1b clinical trial of CB307 through the additi... |
| 11.07.2023 | 2022 Sustainability Report | For the first year, Andera Partners has published a Sustainability strategy covering responsible investment, climate, biodiversity, inclusion and value sharing. |
| 06.07.2023 | PAI Partners to acquire majority stake in Infra Group | PAI Partners (“PAI”), a pre-eminent private equity firm, today announces its agreement to acquire a majority stake in Infra Group, a multi-disciplinary network infrastructure services provider. Upon completion, PAI will become the largest s... |
| 04.07.2023 | ELAN Languages completes acquisition of German group Lingua-World GmbH | ElaN Languages, which has a turnover of around €20m, has built up a solid reputation over the past 30 years for the high quality of its services to a highly demanding clientele, including the Belgian national and regional governments, the E... |
| 29.06.2023 | Andera Acto supports Auris Group in restructuring of its capital and in its development strategy | Paris, 29 June 2023 – |
| 27.06.2023 | Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections | Allecra Therapeutics (“Allecra”) announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for cefepime/enmetazobactam, an antibiotic combination of the fourth generation cephalosporin cef... |
| 19.06.2023 | Siparex ETI finalises agreement to become majority shareholder of Passman group | Passman, leader in networks management and digital solutions for hospitality establishments, will open up its capital to Siparex ETI as a new majority shareholder, allowing LBO France to exit. Andera Partners, the historic shareholder, will... |
| 14.06.2023 | Andera Partners and Pauwels Consulting management team join forces to accelerate the development of the group | Founded in 1999 by its CEO Bert Pauwels, Pauwels Consulting has achieved a leading market position as a consulting and staffing company focused on high skilled profiles to address Life Sciences, IT, and Engineering white collar niches. With... |
| 01.06.2023 | Inotrem announces publication of two key articles on nangibotide Phase II programs in peer-reviewed medical journals | Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and chronic inflammatory conditions, announced today the publication of the results of two phase 2 clinical studies in the The Lancet Respiratory ... |
| 15.05.2023 | Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases | Andera Partners co-leads a €40 million Series A financing of Dualyx NV, a Ghent, Belgium based biotech developing next generation immune modulators. Alongside Andera, Fountain Healthcare Partners and Forbion co-led the round, with support f... |
| 10.05.2023 | Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence in the German, Austrian and Swiss private equity markets | Accelerating its ambitions in the German, Austrian and Swiss (DACH) region, Andera Partners is pleased to announce the appointment of Stefan Keitel as Senior Advisor. Mr. Keitel joins Andera Partners, a leading European private equity firm,... |
| 25.04.2023 | OneXillium group partners with Andera Acto to support them in their next development cycle | Established in 1989 and based in the Netherlands in Woerden, OneXillium has since the outset acted as one of the principal partners of Xerox in the Netherlands and in Europe. Later and through acquisitions, its business was extended to othe... |
| 20.04.2023 | Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients | Tubulis and Bristol Myers Squibb (NYSE: BMY) today announced that they have entered into a strategic license agreement to develop differentiated antibody-drug conjugates (ADCs). |
| 18.04.2023 | Andera Partners co-leads a Series A extension round of € 47.75 million for radiopharmaceutical company Ariceum Therapeutics | Andera Partners, a leading European private equity player, today announces the successful completion of a Series A extension financing, co-led with Earlybird Venture Capital, for Ariceum Therapeutics (Ariceum), a radiopharmaceutical special... |
| 13.04.2023 | Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® | Andera Partners, a leading European private equity player, today announces that it is leading a $48.5 million Series A financing round for medical device company BioVentrix, Inc. BioVentrix is developing minimally invasive therapies to dire... |
| 05.04.2023 | BEA Group (Andera Acto) expands in Italy, through acquisition of Capanna | PARIS, 5 april 2023 – BEA Group, supported by Andera Partners, announces the acquisition of the Capanna Group, a historic player on the Italian insurance market specialised in disaster recovery expertise for Italian and European insurers. D... |
| 29.03.2023 | Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours | Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer neoantigen creation, today announced dosing of the first patient in the initial monotherapy module of ... |
| 22.03.2023 | Andera Acto supports SPS Group, a member of the ECF network, in its capital restructuring | PARIS, 22 MARCH 2023 – Advised by Crédit Agricole Midcap Advisors, the shareholders of SPS are undertaking a capital restructuring around its managing director, Mr. Frédéric Filippi and his team with the support of Andera Partners, a first-... |
| 15.03.2023 | Andera Partners co-leads $25m extension round for FIRE1 | Andera Partners, a leading European private equity player, today announces a $25m extension round, co-led with Novo Holdings, for Irish medtech company, FIRE1 Ltd. The financing provides FIRE1 with capital to accelerate the development of i... |
| 15.03.2023 | NG Travel Group chooses Andera Acto to support them in their capital restructuring | PARIS, 15 MARCH 2023 – Olivier Kervella, director of NG Travel, and his management team chose Andera Acto, the team responsible for the sponsorless mezzanine strategy of Andera Partners, to support the Group in the next phases of its develo... |
| 03.03.2023 | Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focused on Clinical Oncology | Therapeutics (“Flamingo”) and Dynacure, announced today that the companies have signed a definitive merger agreement to combine their pipelines and expertise to create a leading oncology company. The combined company will advance Flamingo’s... |
| 01.03.2023 | Redslim partners with Andera Acto to support them in their next development cycle Redslim partners with Andera Acto to support them in their next development cycle | - |
Show more
Mentions in press and media 107
| Date | Title | Description |
| 16.08.2026 | AI Powers Record VC Rounds, Strategic Tech Gains Momentum | Venture capital aggressively backs artificial intelligence and strategic deep technologies. Databricks leads with a monumental $5 billion raise, solidifying enterprise AI's critical role and market dominance. Geopolitical currents steer sig... |
| 13.08.2026 | Venture Capital & Startup Funding Roundup, August 13, 2026: Blackstone, Coatue, Founders Fund, Sequoia Capital, Thiel Capital & More | Venture dollars are again clustering around AI and infrastructure. Today’s biggest deal saw Databricks haul in a record-breaking $5 billion at a $190 billion valuation. That massive raise – led by Coatue, Blackstone, MGX, T. Rowe Price, and... |
| 11.07.2026 | Andera Expansion Secures Record €430 Million Growth Fund | Andera Expansion's AE IV fund closed at an unprecedented €430 million, significantly exceeding its hard cap due to overwhelming investor demand. This landmark achievement solidifies its position as a leading growth fund. The success stems f... |
| 10.07.2026 | Andera Expansion Raises Record €430 Million For Fourth Growth Fund | Andera Partners has closed its fourth Andera Expansion fund (AE IV) at €430 million, setting a new fundraising record for the growth-focused strategy and coming in well above its original €350 million hard cap. The cap was raised twice to a... |
| 08.07.2026 | Cyllene Therapeutics Raises €33 Million Series C | Cyllene Therapeutics announced the closing of a €33 million Series C financing round. The company was formerly known as EG 427 and rebranded to Cyllene Therapeutics alongside the financing. The round was co-led by GordonMD Global Investment... |
| 08.07.2026 | Andera Partners announces a record €430M fundraise for Andera Expansion. | A CLEAR AND PROVEN INVESTMENT STRATEGY The new AE IV fundraise is underpinned by particularly solid fundamentals, starting with a top quartile track record. The Expansion team has completed 32 exits with an average multiple of 3.6x, enablin... |
| 07.07.2026 | Cyllene Therapeutics Raises €33M in Series C Funding | Cyllene Therapeutics (fka EG 427), a Paris, France-based, company which specializes in non-replicating HSV-1 (nrHSV-1) vector technology in neurology, raised €33M in Series C funding. GordonMD Global Investments and M Ventures. Existing inv... |
| 13.05.2026 | Andera Partners Leads $20 Million Series D Financing in Rivermark Medical. | Andera Partners, a leading European venture capital and private equity firm, today announced it led a $20 million Series D financing in Rivermark Medical, Inc., a urology-focused medical device company committed to redefining benign prostat... |
| 03.03.2026 | Alveus Therapeutics: $197 Million Series A Raised To Advance Next-Generation Obesity And Metabolic Disease Therapies | Alveus Therapeutics announced the second and final closing of its oversubscribed Series A financing, increasing the total round size to $197 million. The clinical-stage biotechnology company, which is developing next-generation therapies fo... |
| 02.03.2026 | Alveus Therapeutics Raises $37M in Series A Extension Funding | Alveus Therapeutics Inc., a Philadelphia, PA-based clinical-stage biotechnology company, raised $37M in Series A Extension funding. The latest round included participation from Jeito Capital and Novo Holdings, joining the original Series A ... |
| 24.01.2026 | TRiCares: Up To €20 Million EIB Loan Secured To Advance Topaz Tricuspid Valve Replacement Trials | TRiCares SAS, a privately held medtech company developing a minimally invasive treatment for tricuspid regurgitation, said it has signed a loan agreement for up to €20 million in non-dilutive financing with the European Investment Bank, the... |
| 22.01.2026 | Exciva Secures €51 Million Series B: Alzheimer's Agitation Therapy Advances to Phase 2 | Exciva closed a €51 million Series B funding round. This financing fuels Deraphan, its Alzheimer's agitation therapy, into crucial Phase 2 trials. EQT Life Sciences and Gimv spearheaded the investment. The global study addresses a pressing ... |
| 20.01.2026 | Exciva: €51 Million Series B Closed To Advance Alzheimer’s Agitation Therapy Into Phase 2 | EQT Life Sciences announced it co-led a €51 million Series B financing in Exciva, a clinical-stage biopharmaceutical company developing treatments for behavioral symptoms associated with Alzheimer’s disease, with proceeds earmarked to move ... |
| 20.01.2026 | Exciva raises €51M in Series B Funding | Exciva, a Heidelberg, Germany-based biopharmaceutical company developing new therapeutic compounds for the treatment of neuropsychiatric conditions, raised €51M in Series B funding. The round was led by Gimv and EQT Life Sciences. Additiona... |
| 13.01.2026 | Alveus Therapeutics Secures $160M Series A for Obesity, Metabolic Disease Innovation | Alveus Therapeutics, a Philadelphia-based biotech company, raised $160M in Series A funding. This significant capital infusion targets advanced therapies for obesity and metabolic diseases. New Rhein, Andera Partners, and Omega Funds led th... |
| 13.01.2026 | Spiro Medical Secures $67M to Revolutionize Asthma Treatment with PNM System | Spiro Medical secured $67 million in Series A funding. This capital fuels development of its innovative Pulmonary Neuromodulation System (PNM). PNM offers a novel, drug-free approach for severe asthma. It uses mild electrical impulses to co... |
| 08.01.2026 | Startup Spiro Medical snares $67M in series A funding for asthma treatment | Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel treatment for asthma. Dubbed the Pulmonary Neuromodulation System, the platform is touted by the company as a first of it... |
| 08.01.2026 | Alveus Therapeutics Raises $160M in Series A Financing | Alveus Therapeutics, a Philadelphia, PA-based clinical-stage biotechnology company, raised $160M in Series A funding. The round was led by New Rhein Healthcare Investors, Andera Partners, and Omega Funds, with participation from Sanofi Capi... |
| 07.01.2026 | Spiro Medical Raises $67M in Series A Funding | Spiro Medical, an Irvine, CA-based medtech company developing a pulmonary neuromodulation system (PNM) for the treatment of asthma, raised $67M in Series A funding. The round included a syndicate of venture investors led by Andera Partners ... |
| 24.12.2025 | TargED: €21.5 Million Series A Extension Raised To Advance Targeted Thrombolytic TGD001 | TargED Biopharmaceuticals B.V., a clinical-stage biotech company developing targeted treatments for thrombotic diseases, has closed a €21.5 million Series A extension led by BioGeneration Ventures (BGV). Existing investors, including Andera... |
| 18.12.2025 | Dutch-based TargED raises €21.5 million Series A extension to advance targeted treatments for thrombotic diseases | Dutch clinical-stage BioTech company TargED Biopharmaceuticals has announced the closing of a €21.5 million Series A extension financing to accelerate the clinical development of its targeted thrombolytic, TGD001. The round was led by BioGe... |
| 19.11.2025 | Artios Pharma Secures $115M to Advance Cancer Therapies | Artios Pharma, a UK-based biotech firm, has secured $115 million in Series D funding. The financing aims to boost the development of its precision cancer treatments. Focus on DNA damage response (DDR) is key. Funds will advance clinical tri... |
| 17.11.2025 | Artios raises $115M Series D to accelerate first-in-class cancer therapies | Biotech company Artios today announced the successful close of an oversubscribed $115 million Series D financing. Artios is pioneering next-generation approaches in the DNA damage response (DDR) field through its comprehensive anti-cancer a... |
| 17.11.2025 | €99 million Series D fuels Artios’ expansion of precision cancer treatment pipeline | Artios Pharma Limited, a British biopharmaceutical company committed to realising the therapeutic potential of targeting the DNA damage response (DDR) in cancer, today announced the successful close of an oversubscribed €99 million ($115 mi... |
| 30.10.2025 | Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M) | MUNICH, GERMANY, October 30, 2025 – Tubulis today announced a second and final closing of its Series C round totaling €344M (US $401M). The second closing brought in additional new investors Fidelity Management & Research Company, Janu... |
| 23.10.2025 | Adcytherix: €105 Million Series A Raised For Advancing Antibody-Drug Conjugate Pipeline And Novel Payload Platform | Adcytherix, a biopharmaceutical company pioneering the design and development of novel antibody-drug conjugates (ADCs), announced the completion of a €105 million (US$122 million) Series A financing round. The funding will accelerate the co... |
| 22.10.2025 | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion Wed, Oct 22, 2025 09:20 CET Report this content Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agre... |
| 16.10.2025 | With its notable €105 million raise, French BioTech startup Adcytherix looks to tackle cancer with novel ADC | Marseille-based Adcytherix, a biopharmaceutical company developing novel and proprietary antibody drug conjugates (ADC), has raised €105 million in a Series A financing round to advance its lead candidate and treat high unmet need diseases ... |
| 16.10.2025 | Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund | Andera Partners, a leading European private equity player, today announced that it has co-led the Series A financing round of Adcytherix, a biopharmaceutical company developing novel and proprietary antibody drug conjugates (ADC). The trans... |
| 15.10.2025 | Tubulis Raises €308M In Series C Funding | Tubulis, a Munich, Germany-based oncology company, closed a €308 million (USD 361m) Series C financing. The round was led by Venrock Healthcare Capital Partners with participation from additional new investors Wellington Management and Asce... |
| 20.02.2025 | EG 427 Secures €27 Million to Revolutionize Neurology Treatments | In a significant leap for biotechnology, Paris-based startup EG 427 has successfully closed a €27 million Series B financing round. This funding, co-led by Andera Partners and Bpifrance, marks a pivotal moment for the company as it aims to ... |
| 20.02.2025 | EG 427 lève 27 millions d’euros lors d’un tour de financement de série B mené conjointement par Andera Partners et Bpifrance pour financer son étude clinique en cours et le développement de sa platefo... | Le fonds spécialisé SCI Ventures, soutenu par les principales fondations dédiées aux blessés médullaires, ainsi que des investisseurs historiques, ont également participé à ce tour de table. Les fonds levés permettront de financer l’étude d... |
| 20.02.2025 | BioTech startup EG 427 raises €27 million to tackle chronic diseases in neurology | EG 427, a Paris-based BioTech startup focused on the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful closing of a €27 million Series B financing round The funding round w... |
| 20.02.2025 | EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development | Specialist fund SCI Ventures, backed by major spinal cord injury foundations, together with existing investors, also participated in this round Proceeds will finance phase 1b/2a study of EG110A through safety and early efficacy results Open... |
| 20.02.2025 | EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development | Specialist fund SCI Ventures, backed by major spinal cord injury foundations, together with existing investors, also participated in this roundProceeds will finance phase 1b/2a study of EG110A through safety and early efficacy results Opens... |
| 20.02.2025 | EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development | EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful closing of a €27 million Series B financing round co-led by Andera Partners an... |
| 14.01.2025 | Bioptimus brings its funding to $76M for the GPT of biology | AI foundation model company Bioptimus has raised a further $41 million cash injection, bringing its funding to $76 million. Bioptimus is redefining how we approach biological research by addressing a longstanding issue: the siloed nature of... |
| 09.01.2025 | FIRE1: $120 Million Funding Raised For Transforming Heart Failure Care | FIRE1 – a leading connected medical device solutions company – announced the completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. The fundin... |
| 08.01.2025 | FIRE1 Secures $120M for Heart Failure Management Platform | What You Should Know: – FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partner... |
| 07.01.2025 | FIRE1 heats up with $120M for its heart failure monitor implant | Things are heating up for FIRE1, which posted a $120 million funding round to support its implant for tracking the hidden signs of heart failure. The Dublin-based company also announced that the FDA has handed down a breakthrough designatio... |
| 07.01.2025 | FIRE1 Secures $120M Financing | FIRE1, a Dublin, Ireland-based connected medical device solutions company, raised $120M in funding. The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and exi... |
| 09.11.2024 | Evommune Secures $115 Million to Tackle Chronic Inflammatory Diseases | In the bustling world of biotechnology, Evommune has made waves. The Palo Alto-based company recently secured $115 million in Series C financing. This funding is a lifeline, aimed at advancing their clinical-stage pipeline focused on immune... |
| 08.11.2024 | Evommune: $115 Million (Series C) Secured To Advance Clinical-Stage Pipeline Addressing Chronic Inflammatory Diseases | Evommune – a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases – announced the completion of a $115 million Series C financing. The funding was co-led by new investors RA... |
| 30.07.2024 | Kestra Medical and T. Rowe Price: Pioneering Innovations in Healthcare and Sustainable Finance | In the ever-evolving landscape of healthcare and finance, two companies are making waves. Kestra Medical Technologies is redefining cardiac care with its innovative wearable devices. Meanwhile, T. Rowe Price is spearheading sustainable inve... |
| 29.07.2024 | Kestra Medical: Wearable Cardioverter Defibrillator Company Closes $196 Million In Funding | Kestra Medical Technologies (a privately held wearable medical device and digital healthcare company) announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its goals of ... |
| 27.07.2024 | TRiCares: Medical Device Company Raises $50 Million In Series D | TRiCares SAS, a privately held pioneer in the minimally invasive treatment of tricuspid regurgitation, announced it has raised $50 million (€46 million) in a Series D funding round. The funding round was raised from a single strategic inves... |
| 26.07.2024 | Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors | Kestra Medical is an American company also present in Ireland, which has developed and commercializes a medical device: a vest equipped with a portable defibrillator for patients at risk of sudden cardiac arrest. The $196 million financing ... |
| 09.07.2024 | Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom | Andera Partners, a leading European private equity player, announced today that it is co-leading a € 63 million ($ 70 million) Series A financing for SciRhom, a biopharmaceutical company pioneering the development of first-in-class therapeu... |
| 14.03.2024 | Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline | Andera Partners’ portfolio company Tubulis today announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. The round was co-led by EQT Life Sciences and Nextech Invest Ltd, on be... |
| 28.02.2024 | Andera Partners raises a final amount of € 233 million for Andera Smart Infra 1, its first fund dedicated to renewable energy transition | The fundraising of Andera Smart Infra 1 highlights the strong interest of investors (including the European Investment Fund under InvestEU) in green infrastructure, resulting from renewable energy and ecological transition requirements. Thi... |
| 05.01.2024 | Transforming Banking and Finance: Can This French Startup Revolutionise the Industry? | Table of Contents show 1 Key Takeaways: 2 Introduction: 3 What differentiates Andera Partners: 4 Conclusion and the future of Andera Partners: Key Takeaways: Andera Partners is an innovative startup based in Paris, focusing on private equit... |
| 27.12.2023 | Ingenostrum accelerates, with a fund raising of 25M€ from Andera Partners | 27/12/2023 Nota de prensa INGENOSTRUM ACCELERATES, WITH A FUND RAISING OF 25M€ FROM ANDERA PARTNERS Ingenostrum, is a leading energy transition player in Spain, developing photovoltaic (PV) projects, as well as data center projects using PV... |
| 14.11.2023 | Nouscom raises CHF65 million in oversubscribed Series C financing round | |
| 14.11.2023 | Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immunotherapy company Nouscom | Andera Partners, a leading European private equity player, today announces that it is co-leading a €67.5 million ($72 million) oversubscribed Series C financing for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf ... |
| 18.09.2023 | Andera Partners increases the hard cap for Andera MidCap 5 and raises a final amount of €750 million | This fundraising success highlights the strong interest investors have in the deep and resilient European and French Lower-Mid Market, as well as in the change of scale strategy led by Andera MidCap which has already delivered solid perform... |
| 15.05.2023 | Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic | May 15, 2023 |
| 15.05.2023 | Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases | Andera Partners co-leads a €40 million Series A financing of Dualyx NV, a Ghent, Belgium based biotech developing next generation immune modulators. Alongside Andera, Fountain Healthcare Partners and Forbion co-led the round, with support f... |
| 18.04.2023 | Andera Partners co-leads a Series A extension round of € 47.75 million for radiopharmaceutical company Ariceum Therapeutics | Andera Partners, a leading European private equity player, today announces the successful completion of a Series A extension financing, co-led with Earlybird Venture Capital, for Ariceum Therapeutics (Ariceum), a radiopharmaceutical special... |
| 13.04.2023 | Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® | Andera Partners, a leading European private equity player, today announces that it is leading a $48.5 million Series A financing round for medical device company BioVentrix, Inc. BioVentrix is developing minimally invasive therapies to dire... |
| 15.03.2023 | Andera Partners co-leads $25m extension round for FIRE1 | Andera Partners, a leading European private equity player, today announces a $25m extension round, co-led with Novo Holdings, for Irish medtech company, FIRE1 Ltd. The financing provides FIRE1 with capital to accelerate the development of i... |
| 15.03.2023 | All smiles as Fire1 raises $25 million for heart failure recovery | Dublin-based medtech firm Fire1, has announced the close of a $25 million financing round to accelerate the development of its monitoring solution to improve outcomes for heart failure patients. The round was led by new investors Andera Par... |
| 26.01.2023 | Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics | Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer neoantigen creation, today announced the closing of an oversubscribed $49 million Series B financing. ... |
| 12.01.2023 | Andera Partners backs $60 million series C for hypertension medtech SoniVie | SoniVie, an Italy and Israel-run med tech seeking to treat hypertension through the use of ultrasound, has closed a $60 million series C round to make headway toward its clinical and regulatory pipeline. Paris-based Andera Partners led the ... |
| 09.01.2023 | Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma | Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced the closing of a €130 million (approx. $138M) Series C equity financing. The financing was led by Sofinn... |
| 09.01.2023 | SoniVie Raises $60m in Round C Financing, and Appoints New Board Members | The funds, provided by new investors and current shareholder, will be used to support the Company clinical and regulatory path towards pre-market approval of its TIVUS™ technology for the treatment of hypertension TEL AVIV, Israel, Jan. 9, ... |
| 17.10.2022 | Digital health news, funding round up in the prior week; October 17, 2022 | Rite Aid partnered with Google Cloud; Walgreens bought CareCentrix; Brave Health raised $40M Top Health News PointClickCare Technologies, a healthcare technology platform enabling collaboration and access to real‐time insights, announced th... |
| 10.10.2022 | Andera Partners Raises Life Sciences Fund, at €456M | Andera Life Sciences, a Paris, France-based business unit of the asset management company Andera Partners specialising in innovative therapeutics and medical technologies , closed its BioDiscovery 6 fund, at €456m. Existing institutional in... |
| 10.10.2022 | Andera Partners: 456 million euros for its largest life sciences fund | Andera Life Sciences has announced the closing of the €456 million financing round of its BioDiscovery-6 fund. With the now sixth generation of BioDiscovery funds, Andera Partners confirms its position as one of the leading venture capital... |
| 10.10.2022 | After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund | Andera Partners has raised its biggest life sciences fund yet. After smashing its previous record in 2017, the European VC shop has gone one better again this time around, reeling in 456 million pounds ($443 million) to make a fresh round o... |
| 10.10.2022 | Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of its activity and of the sector | The sixth generation of BioDiscovery funds is consolidating Andera Partners’ position as one of the leading players in life sciences venture capital in Europe. Existing institutional investors of the BioDiscovery funds have chosen to renew ... |
| 08.06.2022 | Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension | Andera Partners, a leading European private equity player, announced today that, together with RA Capital Management, it is leading an oversubscribed and up-sized $118 million Series B financing for Mineralys Therapeutics, Inc., a private, ... |
| 13.05.2022 | Andera Partners announces the intermediate closing of its new fund Andera MidCap 5 at €450m | Andera Partners – a leading private equity player focusing on small- and mid-sized growth companies in France and internationally – has announced the first closing at €450m of its fund Andera MidCap 5, the successor to Winch Capital 4 (€445... |
| 12.05.2022 | Rewriting the rulebook of HR, Paris startup brings home €225 million | Paris-based HR digital transformation company HR Path has raised €225 million in funding to boost growth, both organically and externally, and expand its operations in the 19 countries it is currently operating in. The investment was led by... |
| 03.05.2022 | Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs | Andera Partners, a leading European private equity player, through its biotech and medtech practice Andera Life Sciences, announced today that it is leading a €60 million (USD $63 million) Series B financing round for Tubulis with participa... |
| 01.04.2022 | COMPAGNIE LEBON : Lancement d'une activité de co-investissement par Andera Partners et Compagnie Lebon | Andera Partners Compagnie Lebon Paris, le 1er avril 2022 à 8h30 Lancement d’une activité de co-investissement par Andera Partners et Compagnie Lebon A l’initiative d’Andera Partners, qui crée ainsi sa sixième activité, et en partenariat ave... |
| 22.02.2022 | TargED Biopharmaceuticals raises EUR 39 Million in Series A financing | TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients • Financing with equal contribution by an international investor syndicate comprising of Andera Partners, Fu... |
| 25.01.2022 | DeFi Technologies Closes CHF 25 Million Investment in Swiss Global Digital Assets Bank, SEBA Bank AG | DeFi Technologies reinforces its goal of providing greater investor access to the growing decentralized finance and Web 3.0 space. The successful financing round was oversubscribed at CHF110 mln and included a consortium of specialized bloc... |
| 25.01.2022 | DeFi Technologies Announces Closing of CHF 25 Million Investment in SEBA Bank AG (A Swiss Global Digital Assets Bank) | DeFi Technologies reinforces the company's presence in providing greater investor access to the growing decentralized finance and Web 3.0 space. The Successful financing round was over-subscribed at CHF110 mln and included a consortium of s... |
| 31.12.2021 | MRHB DeFi Closes Successful USD5.5M Fundraise with IDO and Announces 5 Million Pool of MRHB Token Rewards for Liquidity Providers | MELBOURNE, Australia, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The world’s first ethical and halal DeFi ecosystem platform MRHB DeFi officially concluded its successful fundraising with its final public IDO rounds on DODO and ZeeDO launchpads, alt... |
| 15.12.2021 | DeFi Project Single Finance Raises $1.2M in Seed Round | Single Finance raises $1.2m to launch the first liquidity mining past performance database and pseudo market-neutral strategy platform. Their users will be able to execute pseudo market-neutral leveraged liquidity mining strategies with opt... |
| 09.12.2021 | Andera Partners announces 1st closing at €84m for Andera Smart Infra 1 | Andera Partners, a leading private equity player focusing on high-growth SMEs and mid-caps in France and internationally, has completed an initial €84 million fundraising for its Andera Smart Infra 1 fund. This success reflects investors’ s... |
| 03.12.2021 | Popcorn, Humanitarian-Focused DeFi Platform, Raises $5.8M in Token Launch Auction; $11.2M Raised Total | Boston, Massachusetts--(Newsfile Corp. - December 3, 2021) - Popcorn, a decentralized finance (DeFi) platform that leverages DeFi yield generation strategies to simultaneously create positive social impact, has successfully completed their ... |
| 02.12.2021 | DeFi: Structure Raises $20 Million in Round Led by Polychain Capital | Structure, a DeFi trading platform, has raised $20 million in a round led by Polychain Capital. The funding was completed via a sale of its token $STXR. The investment set a valuation of Structure at $150 million. Other investors beyond Pol... |
| 25.11.2021 | DeFi privacy protocol Panther raises $22M in a public token sale Show your support for our mission by joining our Cube Club and Cube Event Community of experts. Join the community that includes Amazo... | Panther Protocol, an interoperable end-to-end privacy protocol for decentralized finance, today announced that it has raised $22 million during its recent public token sale. The sale, which closed in only 90 minutes, brings the total amount... |
| 04.10.2021 | Finanțări pentru startup-uri medicale europene prin fonduri de investiții de 1,7 miliarde Euro | Startup-urile și firme mai dezvoltate, care inovează în medicină și alte științe ale vieții, au la dispoziție finanțări totale 1,7 miliarde de euro, prin 8 fonduri de investiții europene, susținute de UE și de mari companii, precum Google. ... |
| 16.09.2021 | Andera Partners leads Amolyt Pharma’s $80 million Series B alongside Sectoral Asset Management | Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has closed an $80 million Series B equity financing round. The financing was co-led by ... |
| 16.09.2021 | Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners | LYON, France and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has closed an $80... |
| 09.09.2021 | Andera Partners leads US$ 83 million series A round in Evommune Inc. for the development of transformative therapies in chronic inflammatory diseases. | Evommune was founded in 2020 by industry veterans and former senior leaders at Dermira, a dermatology company acquired by Eli Lilly in 2020, , including Luis Peña, president and chief executive officer, Eugene A. Bauer, MD, chief medical of... |
| 25.08.2021 | DeFi Lending Protocol Euler Closes $8M Series A Round Led By Paradigm | The developers of Euler, the first lending protocol that allows users to create their own lending markets in a permissionless fashion, announced today that they have completed an $8 million Series A round led by Paradigm. The new funding wi... |
| 02.08.2021 | PRESS RELEASE : Andera Partners' Portfolio Company T-knife Announces USD110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies | DGAP-News: Andera Partners / Key word(s): Financing Andera Partners' Portfolio Company T-knife Announces USD110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies 2021-08-02 / 14:05 The issuer is solely responsible ... |
| 02.08.2021 | Andera Partners' : Portfolio Company T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies | DGAP-News: Andera Partners / Key word(s): Financing Andera Partners' Portfolio Company T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies 02.08.2021 / 14:05 The issuer is solely responsible fo... |
| 13.05.2021 | Mobile DeFi Application Alice Raises $2 Million Through Seed Investment Round | Alice, a mobile Decentralized Finance (DeFi) application, announced on Thursday it raised $2 million through its latest seed funding round, which was led by Arrington Capital. Alice is reportedly powered by Terra, the Proof-of-Stake blockch... |
| 27.04.2021 | Andera Partners : strengthens its presence in the DACH region | DGAP-News: Andera Partners / Key word(s): Expansion Andera Partners strengthens its presence in the DACH region 27.04.2021 / 10:00 The issuer is solely responsible for the content of this announcement. Paris and Munich, 27th April 2021 Ande... |
| 01.04.2021 | DeFi Startup Gro Secures $7.1M in Seed Funding to Make Decentralized Finance Market More Accessible | Gro has acquired $7.1 million via a seed round in order to make DeFi more accessible The Gro team writes in a blog post that they’re pleased to confirm that some great business partners and investors have helped them with building their vis... |
| 09.03.2021 | DeFi Technologies Closes $10 Million Private Placement | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 09, 2021 (GLOBE NEWSWIRE) -- DeFi Technologies Inc. (the “Company” or “DeFi”) (NEO: DEFI, GR: RMJR) is pleased to announce that... |
| 11.02.2021 | MedLumics cierra una ronda de €18M a la que acuden Kurma Partners, VI Partners Swiss, CDTI, Asabys Partners, Andera Partners, Caixa Capital Risc e Innogest | 11/02/2021 Nota de prensa MEDLUMICS CIERRA UNA RONDA DE €18 MILLONES. PARTICIPAN, ENTRE OTROS, KURMA PARTNERS, CDTI, ASABYS PARTNERS, ANDERA PARTNERS, CAIXA CAPITAL RISC E INNOGEST. La empresa española de dispositivos médicos MedLumics h... |
| 30.10.2020 | KingSwap, a DeFi Project, Reports $20 Million in Funding and “Liquidity Support” | KingSwap a DeFi (decentralized finance) project has announced that it has raised over $20 million in funding and liquidity support. KingSwap expects to go live on Uniswap this Saturday, October 31, 2020. KingSwap says it set a soft cap of 1... |
| 30.10.2020 | First Regulated DeFi Project KingSwap Raises $20 Million in Funding and Liquidity Support, Announces Public Launch on Uniswap | Singapore, Oct. 30, 2020 (GLOBE NEWSWIRE) -- (via Blockchain Wire) KingSwap (https://www.kingswap.io/), the regulated DeFi project introducing a liquidity pool platform with fiat conversions, today announced it has raised over $20 million i... |
| 09.10.2020 | Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest | Medlumics, which develops Ablaview®, a unique RF irrigated ablation catheter system that merges photonics and miniaturized optics to guide device placement and directly assess the ablation lesions in real time, announces today the closing o... |
| 15.02.2019 | Axovant spin-off launched in Basel with an initial funding of over CHF100m |
Show more